These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
451 related articles for article (PubMed ID: 16825867)
1. Rapid desensitization for hypersensitivity reactions to chemotherapy agents. Castells M Curr Opin Allergy Clin Immunol; 2006 Aug; 6(4):271-7. PubMed ID: 16825867 [TBL] [Abstract][Full Text] [Related]
2. Rapid desensitization of hypersensitivity reactions to chemotherapy agents. Castells M Curr Drug Saf; 2006 Aug; 1(3):243-51. PubMed ID: 18690934 [TBL] [Abstract][Full Text] [Related]
3. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. Castells MC; Tennant NM; Sloane DE; Hsu FI; Barrett NA; Hong DI; Laidlaw TM; Legere HJ; Nallamshetty SN; Palis RI; Rao JJ; Berlin ST; Campos SM; Matulonis UA J Allergy Clin Immunol; 2008 Sep; 122(3):574-80. PubMed ID: 18502492 [TBL] [Abstract][Full Text] [Related]
4. Acetylsalicylic acid and montelukast block mast cell mediator-related symptoms during rapid desensitization. Breslow RG; Caiado J; Castells MC Ann Allergy Asthma Immunol; 2009 Feb; 102(2):155-60. PubMed ID: 19230468 [TBL] [Abstract][Full Text] [Related]
5. Desensitization for hypersensitivity reactions to medications. del Carmen Sancho M; Breslow R; Sloane D; Castells M Chem Immunol Allergy; 2012; 97():217-33. PubMed ID: 22613865 [TBL] [Abstract][Full Text] [Related]
6. Rapid drug desensitization for hypersensitivity reactions to chemotherapy and monoclonal antibodies in the 21st century. Castells Guitart MC J Investig Allergol Clin Immunol; 2014; 24(2):72-9; quiz 2 p following 79. PubMed ID: 24834769 [TBL] [Abstract][Full Text] [Related]
7. Desensitization regimens for drug allergy: state of the art in the 21st century. Liu A; Fanning L; Chong H; Fernandez J; Sloane D; Sancho-Serra M; Castells M Clin Exp Allergy; 2011 Dec; 41(12):1679-89. PubMed ID: 21883538 [TBL] [Abstract][Full Text] [Related]
8. Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment. Madrigal-Burgaleta R; Berges-Gimeno MP; Angel-Pereira D; Ferreiro-Monteagudo R; Guillen-Ponce C; Pueyo C; Gomez de Salazar E; Alvarez-Cuesta E Allergy; 2013 Jul; 68(7):853-61. PubMed ID: 23647576 [TBL] [Abstract][Full Text] [Related]
9. Outcomes and safety of rapid desensitization for chemotherapy hypersensitivity. Limsuwan T; Castells MC Expert Opin Drug Saf; 2010 Jan; 9(1):39-53. PubMed ID: 20001753 [TBL] [Abstract][Full Text] [Related]
10. Outpatient rapid 4-step desensitization for gynecologic oncology patients with mild to low-risk, moderate hypersensitivity reactions to carboplatin/cisplatin. Li Q; Cohn D; Waller A; Backes F; Copeland L; Fowler J; Salani R; O'Malley D Gynecol Oncol; 2014 Oct; 135(1):90-4. PubMed ID: 25110329 [TBL] [Abstract][Full Text] [Related]
11. Rapid inpatient/outpatient desensitization for chemotherapy hypersensitivity: standard protocol effective in 57 patients for 255 courses. Lee CW; Matulonis UA; Castells MC Gynecol Oncol; 2005 Nov; 99(2):393-9. PubMed ID: 16054201 [TBL] [Abstract][Full Text] [Related]
12. Hypersensitivity to antineoplastic agents. Castells MC Curr Pharm Des; 2008; 14(27):2892-901. PubMed ID: 18991707 [TBL] [Abstract][Full Text] [Related]
13. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization. Wong JT; Ling M; Patil S; Banerji A; Long A J Allergy Clin Immunol Pract; 2014; 2(1):40-5. PubMed ID: 24565767 [TBL] [Abstract][Full Text] [Related]
14. Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol. Gammon D; Bhargava P; McCormick MJ Oncologist; 2004; 9(5):546-9. PubMed ID: 15477639 [TBL] [Abstract][Full Text] [Related]
15. Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments. Feldweg AM; Lee CW; Matulonis UA; Castells M Gynecol Oncol; 2005 Mar; 96(3):824-9. PubMed ID: 15721432 [TBL] [Abstract][Full Text] [Related]
16. Indications, protocols, and outcomes of drug desensitizations for chemotherapy and monoclonal antibodies in adults and children. Hong DI; Dioun AF J Allergy Clin Immunol Pract; 2014; 2(1):13-9; quiz 20. PubMed ID: 24565764 [TBL] [Abstract][Full Text] [Related]
17. Drug desensitization in the management of hypersensitivity reactions to monoclonal antibodies and chemotherapy. Mezzano V; Giavina-Bianchi P; Picard M; Caiado J; Castells M BioDrugs; 2014 Apr; 28(2):133-44. PubMed ID: 23990250 [TBL] [Abstract][Full Text] [Related]
18. Treatment outcomes of rapid desensitisation protocols for chemotherapeutic agents and monoclonal antibodies following hypersensitivity reactions. Kuo JC; Hawkins C; Yip D Intern Med J; 2014 May; 44(5):442-9. PubMed ID: 24393214 [TBL] [Abstract][Full Text] [Related]
19. Management and preparedness for infusion and hypersensitivity reactions. Lenz HJ Oncologist; 2007 May; 12(5):601-9. PubMed ID: 17522249 [TBL] [Abstract][Full Text] [Related]
20. Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment. Brennan PJ; Rodriguez Bouza T; Hsu FI; Sloane DE; Castells MC J Allergy Clin Immunol; 2009 Dec; 124(6):1259-66. PubMed ID: 19910036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]